|
Market Closed -
OTC Markets
23:54:33 15/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 0.2600 USD | +4.00% |
|
+4.00% | +114.88% |
| Market Cap | 1.55M 1.35M 1.27M 1.16M 2.17M 148M 2.18M 15.25M 5.89M 75.46M 5.81M 5.68M 243M | P/E 2023 |
-25x | P/E 2024 | -5.75x |
|---|---|---|---|---|---|
| Enterprise Value | 1.06M 928K 877K 796K 1.49M 102M 1.5M 10.5M 4.05M 51.94M 4M 3.91M 167M | EV / Sales 2023 |
0.34x | EV / Sales 2024 | 0.28x |
| Free-Float |
35.53% | Yield 2023 * |
-
| Yield 2024 | - |
| 1 day | +4.00% | ||
| 1 week | +4.00% | ||
| Current month | +4.00% | ||
| 1 month | +4.00% | ||
| 3 months | +29.35% | ||
| 6 months | +38.30% | ||
| Current year | +114.88% |
| 1 week | 0.26 | 0.26 | |
| 1 month | 0.25 | 0.26 | |
| Current year | 0.12 | 0.28 | |
| 1 year | 0.1 | 0.28 | |
| 3 years | 0 | 0.34 | |
| 5 years | 0 | 0.64 | |
| 10 years | 0 | 1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Justice Anderson
CEO | Chief Executive Officer | 49 | 09/01/2018 |
James Anderson
CEO | Chief Executive Officer | 56 | 22/09/2005 |
| Director | Title | Age | Since |
|---|---|---|---|
Justice Anderson
BRD | Director/Board Member | 49 | 01/01/2006 |
James Anderson
BRD | Director/Board Member | 56 | 01/12/2006 |
Regina Anderson
CHM | Chairman | 79 | 01/09/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/7/24 | Other | Director | 12,848 | 0.1585% | ||
| 31/7/24 | Other | Director | 7,200 | 0.0888% | ||
| 31/7/24 | Other | Director | 5,600 | 0.0691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.00% | +4.00% | +154.90% | -5.54% | 2.13M | ||
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | ||
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | ||
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | ||
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | ||
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | ||
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | ||
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | ||
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | ||
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | ||
| Average | +0.43% | +2.93% | +38.21% | +40.26% | 360.17B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2023 | 2024 | |
|---|---|---|
| Net sales | 4.69M 4.09M 3.86M 3.5M 6.57M 450M 6.59M 46.22M 17.84M 229M 17.61M 17.21M 736M | 4.98M 4.35M 4.1M 3.73M 6.98M 478M 7.01M 49.16M 18.97M 243M 18.72M 18.31M 782M |
| Net income | -50.24K -43.81K -41.37K -37.57K -70.39K -4.82M -70.68K -496K -191K -2.45M -189K -185K -7.89M | -341K -297K -281K -255K -478K -32.73M -480K -3.36M -1.3M -16.64M -1.28M -1.25M -53.55M |
| Net Debt | -427K -373K -352K -320K -599K -41.02M -601K -4.22M -1.63M -20.85M -1.61M -1.57M -67.1M | -482K -420K -397K -360K -675K -46.26M -678K -4.75M -1.83M -23.52M -1.81M -1.77M -75.68M |
Employees
20
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|
- Stock Market
- Stocks
- PCYN Stock
Select your edition
All financial news and data tailored to specific country editions
















